Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest Content
Archive
For authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest Content
Archive
For authors
About
Podcasts
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 7, Issue 2
Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
XML
Psoriatic arthritis
Original research
Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials
Online download statistics by month:
Online download statistics by month: May 2021 to December 2022
Abstract
Full
Pdf
May 2021
299
292
146
Jun 2021
218
209
98
Jul 2021
94
92
35
Aug 2021
70
65
32
Sep 2021
79
77
37
Oct 2021
91
89
91
Nov 2021
54
51
29
Dec 2021
49
43
10
Jan 2022
45
42
21
Feb 2022
57
53
32
Mar 2022
64
71
36
Apr 2022
61
60
30
May 2022
75
74
34
Jun 2022
52
53
27
Jul 2022
63
63
21
Aug 2022
55
57
29
Sep 2022
72
73
24
Oct 2022
77
77
29
Nov 2022
49
48
16
Dec 2022
32
32
18
Total
1656
1621
795
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?